Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Retatrutide is supplied exclusively for laboratory research, analytical testing, and scientific investigation purposes
Our IV therapy is administered by trained medical professionals in a controlled environment to minimize risks, such as infection or vein irritation
First, she notes that women of reproductive age with overweight or obesitya large share of people taking these medicationsare more likely to have polycystic ovarian syndrome (PCOS)
The company is planning another Phase 2b trial to assess multiple monthly doses in obesity with preliminary data expected in ear-end-2025 or early-2026
2022 Apr 26;23(9):4783
US$ 22.89
US$ 21.45
US$ 29.62
US$ 24.04
